Quest Diagnostics (DGX) will raise its quarterly dividend by 11.1 percent to $0.50 per share in the first quarter of 2018. This marks the 8th consecutive year of dividend increases by the clinical lab results database provider.
The increased dividend is payable on April 18, 2018 to shareholders of record of Quest Diagnostics common stock on April 4, 2018. This dividend increase is the company's seventh since 2011. The new dividend for Quest Diagnostics is 1.9%.
Quest Diagnostics Incorporated is a provider of diagnostic information services. Quest Diagnostics ows the world's largest database of clinical lab results and the company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. DGX's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.